Literature DB >> 10336090

Comparison of the half-lives and regeneration rates of blood clotting factors II, VII, and X in anticoagulant-resistant and susceptible Norway rats (Rattus norvegicus Berk.).

G M Kerins1, A D MacNicoll.   

Abstract

The half-lives and regeneration rates of clotting factors II, VII, and X in the plasma of anticoagulant-resistant and susceptible rats were determined. There is little or no difference in the half-lives of factors II and X in anticoagulant-resistant rats compared to susceptible rats, but the half-life of factor VII is longer in anticoagulant-resistant rats. In anticoagulant-resistant rats critical clotting factors appear to be carboxylated in preference to factor II, whereas the opposite occurs in susceptible rats; this may contribute to an animal's resistance status.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10336090     DOI: 10.1016/s0742-8413(98)10128-7

Source DB:  PubMed          Journal:  Comp Biochem Physiol C Pharmacol Toxicol Endocrinol        ISSN: 1367-8280


  3 in total

1.  Comparative pharmacokinetics of difethialone stereoisomers in male and female rats and mice: development of an intra- and inter-species model to predict the suitable formulation mix.

Authors:  Antoine Rached; Virginie Lattard; Ambre Fafournoux; Hervé Caruel; Isabelle Fourel; Etienne Benoit; Sébastien Lefebvre
Journal:  Arch Toxicol       Date:  2022-01-25       Impact factor: 5.153

2.  Determining an approximate minimum toxic dosage of diphacinone in horses and corresponding serum, blood, and liver diphacinone concentrations: a pilot study.

Authors:  Megan C Romano; Kyle A Francis; Jennifer G Janes; Robert H Poppenga; Michael S Filigenzi; Darko Stefanovski; Cynthia L Gaskill
Journal:  J Vet Diagn Invest       Date:  2022-04-02       Impact factor: 1.569

3.  Locus-specific genetic differentiation at Rw among warfarin-resistant rat (Rattus norvegicus) populations.

Authors:  Michael H Kohn; Hans-Joachim Pelz; Robert K Wayne
Journal:  Genetics       Date:  2003-07       Impact factor: 4.562

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.